Terms: = Colorectal cancer AND MUC16, CA125, CA-125 AND Treatment
73 results:
1. Construction and validation of artificial intelligence pathomics models for predicting pathological staging in colorectal cancer: Using multimodal data and clinical variables.
Tan Y; Liu R; Xue JW; Feng Z
Cancer Med; 2024 Apr; 13(7):e6947. PubMed ID: 38545828
[TBL] [Abstract] [Full Text] [Related]
2. Characterizing and forecasting neoantigens-resulting from MUC mutations in COAD.
Chen M; Zhang X; Ming Z; Lingyu ; Feng X; Han Z; An HX
J Transl Med; 2024 Mar; 22(1):315. PubMed ID: 38539235
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy and safety of natural killer cells injection combined with XELOX chemotherapy in postoperative patients with stage III colorectal cancer in China: a prospective randomised controlled clinical trial study protocol.
Geng S; Yu X; Yu S
BMJ Open; 2024 Mar; 14(3):e080377. PubMed ID: 38531576
[TBL] [Abstract] [Full Text] [Related]
4. Differential genetic mutations and immune cell infiltration in high- and low-risk STAD: Implications for prognosis and immunotherapy efficacy.
Deng YY; Sun Y; Wu SJ; Zhang TY; Yang J; Liu K
J Cell Mol Med; 2024 Apr; 28(7):e18174. PubMed ID: 38494839
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic value of dynamic changes of pre- and post-operative tumor markers in colorectal cancer.
Ren G; Zheng G; Du K; Dang Z; Dan H; Dou X; Duan L; Xie Z; Niu L; Tian Y; Zheng J; Feng F
Clin Transl Oncol; 2024 Aug; 26(8):2047-2059. PubMed ID: 38453817
[TBL] [Abstract] [Full Text] [Related]
6. Evaluating the role of wound-healing genes in conjunction with stool routine and serum tumor markers for colorectal cancer diagnosis and prognostic implications.
Yu K; Fang X
Int Wound J; 2024 Mar; 21(3):e14768. PubMed ID: 38446012
[TBL] [Abstract] [Full Text] [Related]
7. Clinical value of circulating tumor cells and hematological parameters in 617 Chinese patients with colorectal cancer: retrospective analysis.
He Y; He X; Zhou Y; Luo S
BMC Cancer; 2023 Jul; 23(1):707. PubMed ID: 37507669
[TBL] [Abstract] [Full Text] [Related]
8. Early Screening of colorectal Precancerous Lesions Based on Combined Measurement of Multiple Serum Tumor Markers Using Artificial Neural Network Analysis.
Ke X; Liu W; Shen L; Zhang Y; Liu W; Wang C; Wang X
Biosensors (Basel); 2023 Jun; 13(7):. PubMed ID: 37504084
[TBL] [Abstract] [Full Text] [Related]
9. Comparative analyses of the prognosis, tumor immune microenvironment, and drug treatment response between left-sided and right-sided colon cancer by integrating scRNA-seq and bulk RNA-seq data.
Cao L; Zhang S; Yao D; Ba Y; Weng Q; Yang J; Zhang H; Ren Y
Aging (Albany NY); 2023 Jul; 15(14):7098-7123. PubMed ID: 37480572
[TBL] [Abstract] [Full Text] [Related]
10. Predicting pathologic complete response in locally advanced rectal cancer patients after neoadjuvant therapy: a machine learning model using XGBoost.
Chen X; Wang W; Chen J; Xu L; He X; Lan P; Hu J; Lian L
Int J Colorectal Dis; 2022 Jul; 37(7):1621-1634. PubMed ID: 35704090
[TBL] [Abstract] [Full Text] [Related]
11. Tumour genotypes account for survival differences in right- and left-sided colon cancers.
Ward TM; Cauley CE; Stafford CE; Goldstone RN; Bordeianou LG; Kunitake H; Berger DL; Ricciardi R
Colorectal Dis; 2022 May; 24(5):601-610. PubMed ID: 35142008
[TBL] [Abstract] [Full Text] [Related]
12. Elevated N6-Methyladenosine RNA Levels in Peripheral Blood Immune Cells: A Novel Predictive Biomarker and Therapeutic Target for colorectal cancer.
Xie J; Huang Z; Jiang P; Wu R; Jiang H; Luo C; Hong H; Yin H
Front Immunol; 2021; 12():760747. PubMed ID: 34659267
[TBL] [Abstract] [Full Text] [Related]
13. Molecular Pathways Associated with Kallikrein 6 Overexpression in colorectal cancer.
Pandey R; Zhou M; Chen Y; Darmoul D; Kisiel CC; Nfonsam VN; Ignatenko NA
Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065672
[TBL] [Abstract] [Full Text] [Related]
14. Assessment of structural protein expression by FTIR and biochemical assays as biomarkers of metabolites response in gastric and colon cancer.
Guleken Z; Bulut H; Gültekin Gİ; Arıkan S; Yaylım İ; Hakan MT; Sönmez D; Tarhan N; Depciuch J
Talanta; 2021 Aug; 231():122353. PubMed ID: 33965021
[TBL] [Abstract] [Full Text] [Related]
15. Three phytosterols from sweet potato inhibit MCF7-xenograft-tumor growth through modulating gut microbiota homeostasis and SCFAs secretion.
Han B; Jiang P; Jiang L; Li X; Ye X
Food Res Int; 2021 Mar; 141():110147. PubMed ID: 33642013
[TBL] [Abstract] [Full Text] [Related]
16. The value of haematological parameters and serum tumour markers for predicting KRAS mutations in 784 Chinese colorectal cancer patients: a retrospective analysis.
Cao Y; Gu J; Yan L; Deng S; Mao F; Cai W; Li H; Liu X; Wang J; Wu K; Cai K
BMC Cancer; 2020 Nov; 20(1):1099. PubMed ID: 33183271
[TBL] [Abstract] [Full Text] [Related]
17. Integrated multi-omics data analyses for exploring the co-occurring and mutually exclusive gene alteration events in colorectal cancer.
Zhou Y; Cheng X; Zhang F; Chen Q; Chen X; Shen Y; Lai C; Kota VG; Sun W; Huang Q; Yuan Y; Wang J; Lai M; Zhang D
Hum Mutat; 2020 Sep; 41(9):1588-1599. PubMed ID: 32485022
[TBL] [Abstract] [Full Text] [Related]
18. Diagnostic challenges in synchronous ovarian metastasis from rectal cancer: A case report.
Biolchini F; Castro Ruiz C; Pavesi E; Musci G; Zizzo M; Ugoletti L; Annessi V
Medicine (Baltimore); 2019 Nov; 98(44):e17782. PubMed ID: 31689847
[TBL] [Abstract] [Full Text] [Related]
19. [Clinicopathological characteristics of type 2 diabetes mellitus complicated with colorectal cancer].
Han ZH; Chen JJ; Feng N; Niu PF; Song C; Gao ZY; Gao QK; Ji DB; Wang WB; Lei FM; Gu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Oct; 22(10):966-971. PubMed ID: 31630495
[No Abstract] [Full Text] [Related]
20. Rectal cancer sub-clones respond differentially to neoadjuvant therapy.
Frydrych LM; Ulintz P; Bankhead A; Sifuentes C; Greenson J; Maguire L; Irwin R; Fearon ER; Hardiman KM
Neoplasia; 2019 Oct; 21(10):1051-1062. PubMed ID: 31521947
[TBL] [Abstract] [Full Text] [Related]
[Next]
